Mei, Davide Antonio
 Distribuzione geografica
Continente #
NA - Nord America 3.893
AS - Asia 3.453
EU - Europa 1.685
SA - Sud America 490
Continente sconosciuto - Info sul continente non disponibili 87
AF - Africa 64
OC - Oceania 11
Totale 9.683
Nazione #
US - Stati Uniti d'America 3.697
SG - Singapore 1.123
CN - Cina 997
IT - Italia 843
VN - Vietnam 365
BR - Brasile 352
HK - Hong Kong 297
BD - Bangladesh 198
KR - Corea 164
FI - Finlandia 160
GB - Regno Unito 152
DE - Germania 113
RU - Federazione Russa 99
CA - Canada 93
FR - Francia 83
AR - Argentina 57
ID - Indonesia 54
NL - Olanda 54
IN - India 42
MX - Messico 35
SE - Svezia 28
ES - Italia 26
TR - Turchia 24
PL - Polonia 21
LT - Lituania 20
UZ - Uzbekistan 19
CO - Colombia 18
JP - Giappone 18
PK - Pakistan 18
AT - Austria 17
EC - Ecuador 17
IQ - Iraq 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
JM - Giamaica 15
TW - Taiwan 15
ZA - Sudafrica 15
UA - Ucraina 14
SA - Arabia Saudita 13
VE - Venezuela 12
AU - Australia 10
EG - Egitto 10
BE - Belgio 9
MA - Marocco 9
TH - Thailandia 9
CR - Costa Rica 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
GT - Guatemala 7
IL - Israele 7
KE - Kenya 7
TN - Tunisia 7
CU - Cuba 6
GE - Georgia 6
IE - Irlanda 6
KZ - Kazakistan 6
BO - Bolivia 5
DZ - Algeria 5
JO - Giordania 5
OM - Oman 5
PE - Perù 5
PH - Filippine 5
PT - Portogallo 5
PY - Paraguay 5
RO - Romania 5
BG - Bulgaria 4
MY - Malesia 4
NI - Nicaragua 4
UY - Uruguay 4
AM - Armenia 3
CZ - Repubblica Ceca 3
EE - Estonia 3
HN - Honduras 3
HU - Ungheria 3
NP - Nepal 3
RS - Serbia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CY - Cipro 2
KG - Kirghizistan 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
AO - Angola 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
Totale 9.579
Città #
Singapore 706
Ashburn 619
San Jose 548
Hefei 500
Santa Clara 376
Hong Kong 293
Council Bluffs 284
Seoul 164
Beijing 130
Ho Chi Minh City 124
Los Angeles 122
Helsinki 110
New York 98
Hanoi 87
London 80
Milan 79
Bologna 71
Chicago 70
The Dalles 64
Rome 56
Buffalo 55
Dallas 53
Lauterbourg 46
Munich 42
São Paulo 40
Modena 39
Jakarta 36
Lappeenranta 36
Boardman 32
Kent 29
Moscow 29
Shanghai 27
Orem 26
Salt Lake City 26
Frankfurt am Main 23
Mexico City 21
Phoenix 21
Montreal 19
Naples 19
Amsterdam 18
Nuremberg 18
Belmont 17
Da Nang 17
North Bergen 17
Tashkent 17
Turin 17
Haiphong 16
Portsmouth 15
Seattle 15
Fairfield 14
Houston 14
Indianapolis 14
Lansdowne 14
Miami 14
Tokyo 14
Toronto 14
Warsaw 14
Atlanta 13
Chandler 13
Nyköping 13
Turku 13
Brooklyn 12
Curitiba 12
Newark 12
Stockholm 12
Tampa 12
Vilnius 12
Rio de Janeiro 11
Chennai 10
Columbus 10
Düsseldorf 10
Florence 10
Paris 10
Santiago 10
Denver 9
Hangzhou 9
Istanbul 9
Manchester 9
Salvador 9
Washington 9
Bari 8
Brescia 8
Calgary 8
Campinas 8
Catania 8
Elk Grove Village 8
Ferrara 8
Palermo 8
Perugia 8
Reggio Emilia 8
San Francisco 8
San Salvador 8
Vienna 8
Bengaluru 7
Biên Hòa 7
Boston 7
Brussels 7
Carpi 7
Correggio 7
Fortaleza 7
Totale 5.881
Nome #
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 307
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 296
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 293
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 271
Single-lead VDD pacing: a literature review on short-term and long-term performance 261
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 261
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 248
Remote monitoring and telemedicine in heart failure: implementation and benefits 237
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 224
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 212
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 206
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 194
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 190
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 189
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 188
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 187
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 184
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 178
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 175
Clinical decisions for appropriate management of patients with atrial fibrillation 172
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 171
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 170
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 167
Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: An analysis from the GLORIA-AF registry 161
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 160
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry 152
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 149
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 148
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 147
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry 145
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 137
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 135
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 133
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 133
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 132
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 132
Antiarrhythmic drugs in the era of atrial fibrillation ablation 127
Prepare our healthcare systems to manage complexity: the case of atrial fibrillation 125
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry 124
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial 114
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 113
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 113
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 107
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III 106
Atrial fibrillation screening: The importance of the patient perspective 105
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke 102
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making? 93
Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry 92
Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort 89
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature 84
A European-Multicenter Network for the Implementation of Artificial Intelligence to Manage Complexity and Comorbidities of Atrial Fibrillation Patients: The ARISTOTELES Consortium 79
Female sex as risk factor for undertreatment: need for a paradigm shift in the care of atrial fibrillation and ischaemic disease 73
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry 71
Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey? 70
Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post‐hoc analysis from the WARCEF trial 67
Flecainide and atrial fibrillation cardioversion: what solutions at present and in the near future? 67
Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation 67
Multimorbidity, frailty and polypharmacy in European and Asian patients with atrial fibrillation: a comparison of two regional prospective observational registries 62
Atrial fibrillation ablation in the perspective of holistic patient-centred care: all-cause mortality as an outcome of reference at long-term 59
Mineralocorticoids and outcome improvement in heart failure patients with and without atrial fibrillation: a systematic review and a meta-analysis 58
Antiarrhythmic drugs and ablation in patients with atrial fibrillation: New perspectives 58
Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time? 57
Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project 55
A multistate model of clinical trajectories of heart failure patients with implantable electronic devices followed with remote monitoring: What outcome implications of alerts at long term follow up? 54
Impact of cardiovascular-kidney-metabolic conditions on clinical outcomes in patients with atrial fibrillation: results from a prospective cohort 43
Detection of left ventricular hypertrophy through ECG: diagnostic performance and comparison of ten ECG scores in different hypertrophic conditions 43
Application of Artificial Intelligence in the Early Detection and Management of Atrial Fibrillation: State-of-the-art Review 39
From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients 39
In patients with chronic coronary syndrome and high atherothrombotic risk, adding aspirin to OAC increased adverse CV events at 2 y 38
Evolution in the approach to atrial fibrillation: from screening for asymptomatic episodes to implementing artificial intelligence for refined risk prediction 38
The intriguing relationships between atrial fibrillation and heart failure: insights from cardiac implantable electronic devices 37
Intensification of monitoring for improving detection of atrial fibrillation after a presumed "trigger- induced episode" due to potentially reversible factors: what tools and what implications for decision making? 36
Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries 34
Video-Based Remote Photoplethysmography for Atrial Fibrillation Detection: A Systematic Review 30
Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III 29
Renal function in patients with atrial fibrillation: From Virchow's triad to real-world practice 25
Impact of Left Bundle Branch Pacing on Left Ventricular Mechanical Efficiency 16
Totale 9.683
Categoria #
all - tutte 39.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.941


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 0 2 6 0 0 1 3 6 10
2022/2023110 7 6 8 7 5 5 4 12 15 6 27 8
2023/2024427 5 18 26 52 109 47 39 44 9 15 20 43
2024/20251.783 24 12 17 76 205 282 168 139 186 131 292 251
2025/20265.333 342 233 378 662 600 233 693 306 629 490 393 374
2026/20271.986 280 437 507 762 0 0 0 0 0 0 0 0
Totale 9.683